Atlas Trials

Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis

Clinical trial NCT03346369 · COMPLETED

Trial details

NCT number
NCT03346369
Sponsor
Universitair Ziekenhuis Brussel
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Secondary HyperoxaluriaNephrolithiasis
Start date
2017-08-18
Primary completion
2024-08-10
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.